ENTREMED INC·4

May 31, 7:08 PM ET

Ren Ken Keyong 4

4 · ENTREMED INC · Filed May 31, 2013

Insider Transaction Report

Form 4
Period: 2013-05-30
Ren Ken Keyong
Chief Executive Officer
Transactions
  • Award

    Stock Options (Right to Buy)

    2013-05-30+1,000,0001,000,000 total
    Exercise: $1.79Exp: 2023-05-30Common Stock (1,000,000 underlying)
Footnotes (1)
  • [F1]The stock options vest as follows: 25% on the date of grant, and the remainder ratably over three years on a monthly basis.

Documents

1 file
  • 4
    v346755_4.xmlPrimary

    OWNERSHIP DOCUMENT